questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Molécules d'interaction stromale
Molécules d'interaction stromale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Biopsie
Immunohistochimie
Marqueurs tumoraux
Tumeurs
Imagerie par résonance magnétique
Interactions cellulaires
Biopsie
Analyse histologique
Symptômes
5
Croissance tumorale
Symptômes
Tumeurs
Environnement tumoral
Symptômes précoces
Symptômes tardifs
Traitement
Réversibilité des symptômes
Prévention
5
Prévention
Facteurs de risque
Mode de vie sain
Prévention des tumeurs
Dépistage
Détection précoce
Éducation sur le cancer
Sensibilisation
Vaccins
Prévention du cancer
Traitements
5
Thérapies ciblées
Immunothérapie
Efficacité des traitements
Tumeurs
Effets secondaires
Réactions immunitaires
Médecine personnalisée
Profil moléculaire
Thérapies combinées
Efficacité des traitements
Complications
5
Progression tumorale
Complications
Gestion des complications
Suivi médical
Prévisibilité
Interactions tumorales
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Inflammation chronique
Alimentation
Antioxydants
Antécédents familiaux
Prédisposition génétique
Toxines
Exposition environnementale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Molécules d'interaction stromale : Questions médicales les plus fréquentes",
"headline": "Molécules d'interaction stromale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Molécules d'interaction stromale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-08",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Molécules d'interaction stromale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines membranaires",
"url": "https://questionsmedicales.fr/mesh/D008565",
"about": {
"@type": "MedicalCondition",
"name": "Protéines membranaires",
"code": {
"@type": "MedicalCode",
"code": "D008565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Molécule-1 d'interaction stromale",
"alternateName": "Stromal Interaction Molecule 1",
"url": "https://questionsmedicales.fr/mesh/D000071737",
"about": {
"@type": "MedicalCondition",
"name": "Molécule-1 d'interaction stromale",
"code": {
"@type": "MedicalCode",
"code": "D000071737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.875.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Molécule-2 d'interaction stromale",
"alternateName": "Stromal Interaction Molecule 2",
"url": "https://questionsmedicales.fr/mesh/D000071738",
"about": {
"@type": "MedicalCondition",
"name": "Molécule-2 d'interaction stromale",
"code": {
"@type": "MedicalCode",
"code": "D000071738",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.875.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Molécules d'interaction stromale",
"alternateName": "Stromal Interaction Molecules",
"code": {
"@type": "MedicalCode",
"code": "D000071736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter B Stathopulos",
"url": "https://questionsmedicales.fr/author/Peter%20B%20Stathopulos",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, London, ON, N6A 5C1, Canada. Electronic address: pstatho@uwo.ca."
}
},
{
"@type": "Person",
"name": "Paul Sohn",
"url": "https://questionsmedicales.fr/author/Paul%20Sohn",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN."
}
},
{
"@type": "Person",
"name": "Wenting Wu",
"url": "https://questionsmedicales.fr/author/Wenting%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN."
}
},
{
"@type": "Person",
"name": "Marjan Slak Rupnik",
"url": "https://questionsmedicales.fr/author/Marjan%20Slak%20Rupnik",
"affiliation": {
"@type": "Organization",
"name": "Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Chih-Chun Lee",
"url": "https://questionsmedicales.fr/author/Chih-Chun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Using administrative records to support the linkage of census data: protocol for building a longitudinal infrastructure of U.S. census records.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36721801",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23889/ijpds.v7i4.1764"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic rate estimation from Medicare records: Dependence on claim numbers and latent clinical features.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37517509",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbi.2023.104463"
}
},
{
"@type": "ScholarlyArticle",
"name": "Informative missingness: What can we learn from patterns in missing laboratory data in the electronic health record?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36738870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbi.2023.104306"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database.",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/37650032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23889/ijpds.v7i1.1713"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of knowledgebase transition of a clinical decision support system on medication order and alert patterns in an emergency department.",
"datePublished": "2023-12-01",
"url": "https://questionsmedicales.fr/article/38040729",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-40188-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Molécules d'interaction stromale",
"item": "https://questionsmedicales.fr/mesh/D000071736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Molécules d'interaction stromale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Molécules d'interaction stromale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Molécules d'interaction stromale",
"description": "Comment diagnostiquer une interaction stromale ?\nQuels tests sont utilisés pour les molécules stromales ?\nLes marqueurs stromaux sont-ils spécifiques ?\nPeut-on détecter les molécules stromales par imagerie ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Records#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Molécules d'interaction stromale",
"description": "Quels symptômes sont liés aux interactions stromales ?\nLes interactions stromales causent-elles des symptômes ?\nComment les symptômes varient-ils selon les tumeurs ?\nLes symptômes sont-ils précoces ou tardifs ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Records#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Molécules d'interaction stromale",
"description": "Peut-on prévenir les interactions stromales ?\nQuels modes de vie aident à prévenir les tumeurs ?\nLes dépistages réguliers sont-ils utiles ?\nL'éducation sur le cancer est-elle importante ?\nLes vaccins peuvent-ils prévenir les tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Records#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Molécules d'interaction stromale",
"description": "Quels traitements ciblent les molécules stromales ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires des traitements ?\nComment les traitements sont-ils personnalisés ?\nLes traitements sont-ils combinés ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Records#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Molécules d'interaction stromale",
"description": "Quelles complications peuvent survenir ?\nLes interactions stromales aggravent-elles les complications ?\nComment gérer les complications ?\nLes complications sont-elles prévisibles ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Records#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Molécules d'interaction stromale",
"description": "Quels sont les facteurs de risque des interactions stromales ?\nL'alimentation influence-t-elle les risques ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition à des toxines est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D000071736?mesh_terms=Records#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une interaction stromale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biopsies et des analyses immunohistochimiques sont utilisées pour évaluer les interactions stromales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les molécules stromales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et les western blots permettent de quantifier les molécules d'interaction stromale."
}
},
{
"@type": "Question",
"name": "Les marqueurs stromaux sont-ils spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains marqueurs peuvent être spécifiques à des types de tumeurs, mais d'autres sont plus généraux."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les molécules stromales par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques d'imagerie avancées, comme l'IRM, peuvent aider à visualiser les interactions stromales."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'obtenir des échantillons pour analyser les interactions stromales au sein des tumeurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux interactions stromales ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur, inflammation et signes de progression tumorale."
}
},
{
"@type": "Question",
"name": "Les interactions stromales causent-elles des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent influencer la croissance tumorale et provoquer des symptômes associés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les tumeurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent du type de tumeur et de l'environnement stromal spécifique."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils précoces ou tardifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent être précoces ou tardifs, selon la nature de l'interaction stromale."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent s'améliorer avec un traitement ciblant les interactions stromales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les interactions stromales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la réduction des facteurs de risque liés aux tumeurs et à l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à prévenir les tumeurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dépistages peuvent aider à détecter les tumeurs précocement, limitant les interactions stromales."
}
},
{
"@type": "Question",
"name": "L'éducation sur le cancer est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation aide à sensibiliser aux facteurs de risque et aux signes précoces de cancer."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir les tumeurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins, comme ceux contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les molécules stromales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des immunothérapies sont en développement pour cibler ces molécules."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon le type de tumeur et la nature des interactions stromales."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires, notamment des réactions immunitaires."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont adaptés en fonction du profil moléculaire de la tumeur et de l'environnement stromal."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils combinés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des combinaisons de traitements sont souvent utilisées pour améliorer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression tumorale, la résistance au traitement et la métastase."
}
},
{
"@type": "Question",
"name": "Les interactions stromales aggravent-elles les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent favoriser la progression tumorale et compliquer le traitement."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique des traitements ciblés et un suivi régulier pour adapter les thérapies."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées en fonction du type de tumeur et des interactions."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des interactions stromales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'inflammation chronique, le tabagisme et des prédispositions génétiques."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut réduire les risques d'interactions stromales."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer l'inflammation et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer peuvent augmenter le risque d'interactions stromales."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances toxiques peut favoriser les interactions stromales et le cancer."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, London, ON, N6A 5C1, Canada. Electronic address: pstatho@uwo.ca.
Publications dans "Molécules d'interaction stromale" :
3 publications dans cette catégorie
Affiliations :
Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN.
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN.
Publications dans "Molécules d'interaction stromale" :
3 publications dans cette catégorie
Affiliations :
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.
Publications dans "Molécules d'interaction stromale" :
3 publications dans cette catégorie
Affiliations :
Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Institute of Physiology, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Publications dans "Molécules d'interaction stromale" :
3 publications dans cette catégorie
Affiliations :
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN.
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Publications dans "Molécules d'interaction stromale" :
3 publications dans cette catégorie
Affiliations :
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN.
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Richard L. Roudebush Veterans' Administration Medical Center, Indianapolis, IN.
Publications dans "Molécules d'interaction stromale" :
3 publications dans cette catégorie
Affiliations :
Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN.
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN.
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Richard L. Roudebush Veterans' Administration Medical Center, Indianapolis, IN.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN.
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biophysics, University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2M9, Canada. Electronic address: mikura@uhnresearch.ca.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A5C1, Canada.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea, Seoul 06591, Korea.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea, Seoul 06591, Korea.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea, Seoul 06591, Korea.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Xiamen University, College of Chemistry and Chemical Engineering & Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), CHINA.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Xiamen University, College of Chemistry and Chemical Engineering, Siming south road 422, 3012, Xiamen, CHINA.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Physics, Indiana University Indianapolis, Indianpolis, Indiana, USA.
Publications dans "Molécules d'interaction stromale" :
2 publications dans cette catégorie
Affiliations :
Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana, USA.
Publications dans "Molécules d'interaction stromale" :
1 publication dans cette catégorie
Affiliations :
Universiti Sains Malaysia, Advanced Medical and Dental Institute, Department of Biomedical Science, Pulau Pinang, Malaysia
Hadhramout University, Faculty of Medicine and Health Sciences, Department of Basic Medical Sciences, Hadhramout, Yemen
Publications dans "Molécules d'interaction stromale" :
1 publication dans cette catégorie
Affiliations :
Universiti Sains Malaysia, Advanced Medical and Dental Institute, Department of Biomedical Science, Pulau Pinang, Malaysia
Publications dans "Molécules d'interaction stromale" :
This article describes the linkage methods that will be used in the Decennial Census Digitization and Linkage project (DCDL), which is completing the final four decades of a longitudinal census infras...
International Classification of Disorders version 10 (ICD-10) codes contribute heavily to healthcare data. Medicare claims and other data-sources are used to constitute study populations and appraise ...
The study population was Medicare beneficiaries aged 75-79.99 with claim(s) in the 5% standard analytical Carrier and Outpatient files, alive and participating in Medicare part B for all 12 months of ...
Beneficiaries meeting inclusion criteria totaled 221,625, these having 7,617,503 claims; 96.4% had between 1 and 120 claims. Median claims were 24 for males (females 25); modal claims were 11 (13). Av...
Older adult Medicare beneficiaries aged 75-80 exhibited varying claims activity over the course of a year. Although DRE dependence on claim numbers varies across ICD-10 codes, rate estimates are highe...
In electronic health records, patterns of missing laboratory test results could capture patients' course of disease as well as reflect clinician's concerns or worries for possible conditions. These ...
We collected and analyzed demographic, diagnosis, and laboratory data for 69,939 patients with positive COVID-19 PCR tests across three countries from 1 January 2020 through 30 September 2021. We anal...
With these analyses, we identified mapping issues faced in seven out of 15 sites. We also identified nuances in data collection and variable definition for the various sites. Temporal trend analyses m...
In this work, we use computational approaches to relate missingness patterns to hospital treatment capacity and highlight the heterogeneity of looking at COVID-19 over time and at multiple sites, wher...
MedicineInsight is a database containing de-identified electronic health records (EHRs) from over 700 Australian general practices. Previous research validated algorithms used to derive medical condit...
To examine the accuracy of the extraction and transformation of EHR fields for selected demographics, observations, diagnoses, prescriptions, and tests into MedicineInsight....
We benchmarked MedicineInsight values against those recorded in original EHRs. Forty-six general practices contributing data to MedicineInsight met our eligibility criteria, eight were randomly select...
A total of 796 patients were included in our analysis. All demographic characteristics, observations, diagnoses, prescriptions and random pathology test results had excellent (>90%) POA, Kappa, and IC...
Overall, our study shows good agreement between the majority of MedicineInsight data and those from original EHRs, suggesting MedicineInsight data extraction and warehousing procedures accurately cons...
A knowledgebase (KB) transition of a clinical decision support (CDS) system occurred at the study site. The transition was made from one commercial database to another, provided by a different vendor....
Clinical Practice Guidelines (CPGs) provide healthcare professionals with performance and decision-making support during the treatment of patients. Sometimes, however, they are poorly implemented. The...
The main objective of this paper is to present the results of the clinical validation of the IDE...
National and international knowledge sources on T2DM were selected and reviewed and used to define a diabetes CPG model on the IDE...
A concordance analysis was performed with the kappa value. Overall agreement between the recommendations provided by the system and those recorded in each patient's EHR was good (0.61 - 0.80) with a t...
A series of possible improvements were identified based on the limitations for the recovery of variables related to the quality of these recolected variables, the detection of duplicate recommendation...
The main objective of this paper is to assess the efficiency of the European Union's public sector from a quality of governance approach, employing a two-step methodology. In the first stage, EU state...
The balanced development of ecological quality and residents' well-being is an important factor in achieving sustainable economic development in rural counties. In order to promote the improvement of ...
Improving the human reliability of the human-machine interface (HMI) of deep-sea manned submersible is of great importance for the development of the deep-sea field. Based on the SHEL (Software S, Har...
Individuals are increasingly required to interact with complex and autonomous technologies, which often has a significant impact on the control they experience over their actions and choices. A better...